HK1208632A1 - Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae - Google Patents

Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae

Info

Publication number
HK1208632A1
HK1208632A1 HK15109455.2A HK15109455A HK1208632A1 HK 1208632 A1 HK1208632 A1 HK 1208632A1 HK 15109455 A HK15109455 A HK 15109455A HK 1208632 A1 HK1208632 A1 HK 1208632A1
Authority
HK
Hong Kong
Prior art keywords
chimeric protein
streptococcus pneumoniae
vaccine against
protein vaccine
pneumonia caused
Prior art date
Application number
HK15109455.2A
Other languages
English (en)
Chinese (zh)
Inventor
‧蘇沃羅夫
‧杜克浩林夫
‧奧爾洛夫
‧拜古金
Original Assignee
Epitope Ltd Epitope Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitope Ltd Epitope Ltd filed Critical Epitope Ltd Epitope Ltd
Publication of HK1208632A1 publication Critical patent/HK1208632A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HK15109455.2A 2012-06-22 2015-09-25 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae HK1208632A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012126328/15A RU2510281C2 (ru) 2012-06-22 2012-06-22 ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
PCT/RU2013/000525 WO2013191591A1 (en) 2012-06-22 2013-06-21 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae

Publications (1)

Publication Number Publication Date
HK1208632A1 true HK1208632A1 (en) 2016-03-11

Family

ID=49769080

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109455.2A HK1208632A1 (en) 2012-06-22 2015-09-25 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae

Country Status (13)

Country Link
US (1) US9345757B2 (es)
EP (1) EP2863944B1 (es)
JP (1) JP6195089B2 (es)
KR (1) KR20150034192A (es)
CN (1) CN104470538B (es)
BR (1) BR112014032135A2 (es)
CU (1) CU24238B1 (es)
EA (1) EA027981B1 (es)
HK (1) HK1208632A1 (es)
MX (1) MX355642B (es)
RU (1) RU2510281C2 (es)
UA (1) UA116634C2 (es)
WO (1) WO2013191591A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104844712B (zh) * 2015-04-03 2019-06-28 长春百克生物科技股份公司 肺炎链球菌蛋白抗原及其制备方法和应用
RU2591809C1 (ru) * 2015-07-21 2016-07-20 Андрей Дмитриевич Протасов Способ активации факторов противовирусной защиты у пациентов с хронической обструктивной болезнью легких
RU2627602C2 (ru) * 2015-12-29 2017-08-09 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ получения химерного рекомбинантного белка fliC:pagN
EP3548076A2 (en) 2016-12-03 2019-10-09 The UAB Research Foundation Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a
RU2769573C2 (ru) * 2017-08-03 2022-04-04 Интервет Интернэшнл Б.В. Вакцина для защиты от streptococcus suis
RU2687488C1 (ru) * 2018-07-12 2019-05-14 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" ФГБНУ ВНИТИБП Формолвакцина полиштаммная против пневмоний телят стрептококковой этиологии
RU2720614C9 (ru) * 2020-04-23 2021-02-09 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Иммунобиологическое средство и способ его использования для индукции специфического иммунитета против вируса тяжелого острого респираторного синдрома SARS-CoV-2 (варианты)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936252B2 (en) 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
BR0011478A (pt) * 1999-06-10 2002-03-19 Uab Research Foundation Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP2277897A1 (en) 2001-04-16 2011-01-26 Wyeth Holdings Corporation Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
EP2333114A1 (en) 2003-04-15 2011-06-15 Intercell AG S. pneumoniae antigens
EP1477802A1 (en) 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Method for selecting and producing vaccine components and vaccines based thereon
EP2371843B1 (en) 2005-05-19 2014-09-17 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
EP3020411A1 (en) * 2005-12-22 2016-05-18 GlaxoSmithKline Biologicals s.a. Vaccine
WO2009156405A1 (en) * 2008-06-25 2009-12-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel immunoadjuvant flagellin-based compounds and use thereof
WO2010045620A1 (en) * 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US8003112B2 (en) 2009-04-16 2011-08-23 Howard University Meningococcal and pneumococcal conjugate vaccine and method of using same
WO2010141312A2 (en) * 2009-06-01 2010-12-09 Wake Forest University Health Sciences Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same

Also Published As

Publication number Publication date
EA027981B1 (ru) 2017-09-29
KR20150034192A (ko) 2015-04-02
EA201590078A1 (ru) 2015-06-30
UA116634C2 (uk) 2018-04-25
WO2013191591A4 (en) 2014-04-03
WO2013191591A1 (en) 2013-12-27
CU20140145A7 (es) 2015-04-29
JP6195089B2 (ja) 2017-09-20
US9345757B2 (en) 2016-05-24
CN104470538A (zh) 2015-03-25
BR112014032135A2 (pt) 2017-08-01
MX355642B (es) 2018-04-25
CN104470538B (zh) 2017-12-22
RU2012126328A (ru) 2013-12-27
MX2014016049A (es) 2015-07-06
US20150174230A1 (en) 2015-06-25
EP2863944A4 (en) 2016-05-11
EP2863944B1 (en) 2018-12-19
RU2510281C2 (ru) 2014-03-27
EP2863944A1 (en) 2015-04-29
CU24238B1 (es) 2017-02-02
JP2015521618A (ja) 2015-07-30
WO2013191591A9 (en) 2014-02-13

Similar Documents

Publication Publication Date Title
HK1209298A1 (en) Travel pillow
HK1203146A1 (en) Antibody formulation
HK1208632A1 (en) Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae
RS59221B1 (sr) Formulacije antitela
GB201214424D0 (en) Cleaner head
SG10201600435UA (en) Vaccines And Compositions Against Streptococcus Pneumoniae
ZA201308537B (en) Vaccine against streptococcus pneumoniae
PL2814329T3 (pl) ŚRODEK SŁODZĄCY O USTAWIANEJ WARTOŚCI pH
HK1224300A1 (zh) 合成針對 型肺炎鏈球菌的疫苗
HK1211839A1 (en) Pneumococcal vaccine containing pneumococcal surface protein
GB2507316B (en) Thermoelectric transducers
HK1206812A1 (en) Human streptococcus pneumoniae antibodies and uses therefor
GB201215342D0 (en) Thermoelectric elementd
EP2804627A4 (en) CONDENSED ANTIGEN VACCINES AND COMPOSITIONS AGAINST STREPTOCOCCUS PNEUMONIAE
EP2820421A4 (en) DAMPING PAD OF ANTIBODY
GB201216672D0 (en) Travel pillow
GB2505927B (en) Cleaner head
EP2906711A4 (en) METHOD OF DIAGNOSING BACTERIAL INFECTIONS
TH1401007627A (th) วัคซีนชนิดคิเมริกโปรตีนป้องกันโรคปอดอักเสบที่เป็นสาเหตุจาก สเตรปโตคอคคัส นิวโมเนีย
GB2515669B (en) Bacterial vaccine
ZA201304556B (en) Autolatch buffer
GB201214423D0 (en) Cleaner head
GB201214422D0 (en) Cleaner head

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220617